DIA/FDA Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Back to Agenda

DIA Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Session Chair(s)

Representative Invited

Irish Dental Association, Ireland

Attend to learn more or meet fellow members, hear about what’s happening in the working group, and join in the latest discussions on the latest hot topics.